Curtis Gale Oltmans Fulcrum Therapeutics, Inc. (FULC) insider trading activity

FULC Quotes by TradingView

Curtis Gale Oltmans is Chief Legal Officer of Fulcrum Therapeutics, Inc.. Currently has a direct ownership of 10,252 shares of FULC, which is worth approximately $88,884. The most recent transaction as insider was on Dec 15, 2025, when has been sold 3,452 shares (Common Stock) at a price of $12.92 per share, resulting in proceeds of $44,599. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10.3K
842.28% 3M change
842.28% 12M change
Total Value Held $88,884

Curtis Gale Oltmans Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 15 2025
SELL
Open market or private sale
$44,599 $12.92 p/Share
3,452 Reduced 25.19%
10,252 Common Stock
Jun 28 2021
BUY
Open market or private purchase
$9,803 $9.01 p/Share
1,088 Added 50.0%
1,088 Common Stock

Also insider at

ATXI
AVENUE THERAPEUTICS, INC. Healthcare
Director
CGO

Curtis Gale Oltmans

Chief Legal Officer
Cambridge, MA

Track Institutional and Insider Activities on FULC

Follow Fulcrum Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FULC shares.

Notify only if

Insider Trading

Get notified when an Fulcrum Therapeutics, Inc. insider buys or sells FULC shares.

Notify only if

News

Receive news related to Fulcrum Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on FULC